Colorado Blood Cancer — Denver, Colorado

Colorado Blood Cancer is a clinical research site located in Denver, Colorado, United States 80218.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Colorado Blood Cancer has participated in 1 clinical trials.

Therapeutic areas: Recurrent Primary Amyloidosis.

Sponsors: Barbara Ann Karmanos Cancer Institute.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Colorado Blood Cancer?

Colorado Blood Cancer has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Colorado Blood Cancer conducted?

Colorado Blood Cancer has 1 clinical trials on record. Their work covers Recurrent Primary Amyloidosis.

Is Colorado Blood Cancer accredited by Crixeo Health?

Colorado Blood Cancer has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Colorado Blood Cancer?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.